Abstract: Presented are concepts for monitoring a health status of a subject. One such concept employs determining a trend in a health parameter of the subject based input data relating to a plurality of event occurrences for the subject. One or more irregularities are detected in the determined trend and health status of the subject is then determined based on the detected irregularities.

Abstract: Present invention provides a method for diagnosing and prognosing endometrial cancer in easy-to-access isolated samples by detecting the level of expression of one or more proteins. In particular from uterine fluid samples. The invention also provides kits comprising means for detecting said proteins for use in the diagnosis and prognosis of the disease.

Abstract: The present invention provides a method of diagnosis or prognosis endometrial carcinoma, the method comprising determining the level of expression of MMP9 in a uterine aspirate fluid sample from the female genital tract. The present invention further provides kits for the diagnosis of the disease.

Abstract: The maintenance device for at least one hearing aid having an earbud that is connected by an electronic cable to an earloop containing a rechargeable battery includes a device for charging the battery of the hearing aid and an aeraulic circuit that is configured to optimize the drying of the hearing aid.

Abstract: Presented are concepts for monitoring a health status of a subject. One such concept employs determining a trend in a health parameter of the subject based input data relating to a plurality of event occurrences for the subject. One or more irregularities are detected in the determined trend and health status of the subject is then determined based on the detected irregularities.

Abstract: The maintenance device for at least one hearing aid having an earbud that is connected by an electronic cable to an earloop containing a rechargeable battery includes a device for charging the battery of the hearing aid and an aeraulic circuit that is configured to optimize the drying of the hearing aid.

Abstract: Present invention provides a method for diagnosing and prognosing endometrial cancer in easy-to-access isolated samples by detecting the level of expression of one or more proteins. In particular from uterine fluid samples. The invention also provides kits comprising means for detecting said proteins for use in the diagnosis and prognosis of the disease.

Abstract: The present invention provides a method of diagnosis or prognosis endometrial carcinoma, the method comprising determining the level of expression of MMP9 in a uterine aspirate fluid sample from the female genital tract. The present invention further provides kits for the diagnosis of the disease.

Abstract: The present disclosure pertains to a light sensing system configured to determine an amount of ambient light exposure experienced by a subject. The present invention wirelessly exchanges light information between different wearable devices of the same user and/or between devices of different users. Local and/or central light profile databases are built-up by the system and are shared between the devices so that light data that is typical for a location at a specific time of day and year can be used to estimate current ambient light levels for situations in which no measurement can be taken.

Abstract: A flow device for an exhaust system includes a body that defines an interior cavity. An exhaust inlet passage is disposed in the interior cavity. An exhaust outlet passage is disposed in the interior cavity so that at least a portion of the exhaust inlet passage circumferentially surrounds at least a portion of the exhaust outlet passage. A doser is adapted to inject reductants into the interior cavity of the body such that the reductants are injected in the same general direction as the direction of flow of the exhaust gases.

Abstract: The present disclosure pertains to a light sensing system configured to determine an amount of ambient light exposure experienced by a subject. The present invention wirelessly exchanges light information between different wearable devices of the same user and/or between devices of different users. Local and/or central light profile databases are built-up by the system and are shared between the devices so that light data that is typical for a location at a specific time of day and year can be used to estimate current ambient light levels for situations in which no measurement can be taken.

Abstract: A flow device for an exhaust system includes a body that defines an interior cavity. An exhaust inlet passage is disposed in the interior cavity. An exhaust outlet passage is disposed in the interior cavity so that at least a portion of the exhaust inlet passage circumferentially surrounds at least a portion of the exhaust outlet passage. A doser is adapted to inject reductants into the interior cavity of the body such that the reductants are injected in the same general direction as the direction of flow of the exhaust gases.

Abstract: The invention relates to the surprising finding that biomarkers corresponding to ACAA1, AP1M2, CGN, DDR1, EPS8L2, FASTKD1, GMIP, IKBKE, P2RX4, P4HB, PHKG2, PPFIBP2, PPP1R16A, RASSF7, RNF183, SIRT6, TJP3, EFEMP2, SOCS2, and DCN are differentially expressed in control samples as compared to samples from patients having endometrial cancer and are therefore useful for detecting endometrial cancer. In particular these biomarkers having excellent sensitivity, specificity, and/or the ability to separate affected from non affected individuals. Furthermore, the inventors found that the differential expression of these biomarkers in primary endometrial cancer tumor tissue is correlated to their expression level in uterine fluid samples as compared to control values. Thus these biomarkers are robust in that they are found to be differentially expressed in several different types of samples from affected and individuals.

Abstract: A flow device for an exhaust system includes a body that defines an interior cavity. An exhaust inlet passage is disposed in the interior cavity. An exhaust outlet passage is disposed in the interior cavity so that at least a portion of the exhaust inlet passage circumferentially surrounds at least a portion of the exhaust outlet passage. A doser is adapted to inject reductants into the interior cavity of the body such that the reductants are injected in the same general direction as the direction of flow of the exhaust gases.

Abstract: The device for cleaning at least one medical hearing unit includes an earpiece, and a space for receiving the earpiece, the space having at least one seat receiving the earpiece and an orifice with a cavity underneath. There is a circulator for a liquid within the space to contact the earpiece. The cavity includes an outlet for flow or aspiration of liquid, an opening opposite, and, below each orifice, a directing device to guide the liquid towards and under each orifice, as far as the outlet, in such a way that liquid flows across the earpiece.

Abstract: The invention relates to the surprising finding that biomarkers corresponding to ACAA1, AP1M2, CGN, DDR1, EPS8L2, FASTKD1, GMIP, IKBKE, P2RX4, P4HB, PHKG2, PPFIBP2, PPP1 R16A, RASSF7, RNF183, SIRT6, TJP3, EFEMP2, S0CS2, and DCN are differentially expressed in control samples as compared to samples from patients having endometrial cancer and are therefore useful for detecting endometrial cancer. In particular these biomarkers having excellent sensitivity, specificity, and/or the ability to separate affected from non affected individuals. Furthermore, the inventors found that the differential expression of these biomarkers in primary endometrial cancer tumor tissue is correlated to their expression level in uterine fluid samples as compared to control values. Thus these biomarkers are robust in that they are found to be differentially expressed in several different types of samples from affected individuals.

Abstract: A flow device for an exhaust system includes a body that defines an interior cavity. An exhaust inlet passage is disposed in the interior cavity. An exhaust outlet passage is disposed in the interior cavity so that at least a portion of the exhaust inlet passage circumferentially surrounds at least a portion of the exhaust outlet passage. A doser is adapted to inject reductants into the interior cavity of the body such that the reductants are injected in the same general direction as the direction of flow of the exhaust gases.

Abstract: The present invention relates to a device (2) for cleaning at least one medical hearing unit comprising an earpiece (101), said device (2) comprising a space (3) for receiving said earpiece (101), said space (3) comprising at least one seat (4) designed in such a way as to receive said earpiece and comprising, in the lower part, an orifice (11designed such that the distal end of said earpiece extends inside a cavity (12) formed underneath, and means (9) for causing a liquid to circulate within said space (3) in such a way that said liquid comes into contact with said earpiece, characterized in that said cavity (12) comprises at least one outlet (15) for flow or aspiration of said liquid, opening out opposite and below each orifice (11), and in that the bottom of said cavity (12) comprises means (14) for directing said liquid towards and under said orifice (11), as far as said outlet (15), in such a way that said liquid flows across said earpiece, in particular its standard or made-to-measure ear mold.

Abstract: A flow device for an exhaust system includes a body that defines an interior cavity. An exhaust inlet passage is disposed in the interior cavity. An exhaust outlet passage is disposed in the interior cavity so that at least a portion of the exhaust inlet passage circumferentially surrounds at least a portion of the exhaust outlet passage. A doser is adapted to inject reductants into the interior cavity of the body such that the reductants are injected in the same general direction as the direction of flow of the exhaust gases.

Abstract: The invention relates to the surprising finding that biomarkers corresponding to ACAA1, AP1M2, CGN, DDR1, EPS8L2, FASTKD1, GMIP, IKBKE, P2RX4, P4HB, PHKG2, PPFIBP2, PPP1 R16A, RASSF7, RNF183, SIRT6, TJP3, EFEMP2, S0CS2, and DCN are differentially expressed in control samples as compared to samples from patients having endometrial cancer and are therefore useful for detecting endometrial cancer. In particular these biomarkers having excellent sensitivity, specificity, and/or the ability to separate affected from non affected individuals. Furthermore, the inventors found that the differential expression of these biomarkers in primary endometrial cancer tumor tissue is correlated to their expression level in uterine fluid samples as compared to control values. Thus these biomarkers are robust in that they are found to be differentially expressed in several different types of samples from affected individuals.